Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.
Emerg Infect Dis
; 20(2)2014 Feb.
Article
in En
| MEDLINE
| ID: mdl-24457117
ABSTRACT
In August 2012, the Centers for Disease Control and Prevention, in partnership with the Association of Maternal and Child Health Programs, convened a meeting of national subject matter experts to review key clinical elements of anthrax prevention and treatment for pregnant, postpartum, and lactating (P/PP/L) women. National experts in infectious disease, obstetrics, maternal fetal medicine, neonatology, pediatrics, and pharmacy attended the meeting, as did representatives from professional organizations and national, federal, state, and local agencies. The meeting addressed general principles of prevention and treatment for P/PP/L women, vaccines, antimicrobial prophylaxis and treatment, clinical considerations and critical care issues, antitoxin, delivery concerns, infection control measures, and communication. The purpose of this meeting summary is to provide updated clinical information to health care providers and public health professionals caring for P/PP/L women in the setting of a bioterrorist event involving anthrax.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pregnancy Complications, Infectious
/
Bacillus anthracis
/
Anthrax Vaccines
/
Postpartum Period
/
Anthrax
/
Anti-Bacterial Agents
Type of study:
Guideline
Limits:
Adult
/
Female
/
Humans
/
Infant
/
Pregnancy
Country/Region as subject:
America do norte
Language:
En
Journal:
Emerg Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2014
Document type:
Article